glp 1/gip Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy GLP1-GIP receptor co-agonists: a promising
Description
We review your medical history, current medications, and health concerns to determine whether semaglutide is a safe and appropriate treatment for you
in humans, an association between sDPP-4 and triglyceride levels was evidenced, while patients treated for 24 months with a DPP-4is-based combination with metformin exhibited an improved lipid profile, especially for triglycerides and LDL, when compared to baseline in T2D patients [67]
Patients were not allowed to be on any antidiabetic medication during the study except for stable metformin and/or sulfonylurea treatment
You should talk to your doctor about your full medical history before starting either medication
Discussion This scoping review and review summarizes the available literature on the combined use of GLP-1 receptor agonists and SGLT2 inhibitors
F.SchurdakJ
